CTSO Cytosorbents Corp

CytoSorbents Corp is a immunotherapy company. The Company uses blood purification to modulate inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses and cardiac surgery.

$7.46  -0.22 (-2.87%)
As of 07/23/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  08/08/2006
Outstanding shares:  43,319,297
Average volume:  307,855
Market cap:   $332,692,201
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    23283X206
ISIN:        US23283X2062
Sedol:      BTCB1L1
Valuation   (See tab for details)
PE ratio:   -37.79
PB ratio:   4.18
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy